Aihika Herbocare Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 25-06-2024
- Paid Up Capital ₹ 0.50 M
as on 25-06-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 2.29 M
as on 25-06-2024
- Revenue -14.30%
(FY 2020)
- Profit 96.50%
(FY 2020)
- Ebitda 157.82%
(FY 2020)
- Net Worth -6.32%
(FY 2020)
- Total Assets 0.91%
(FY 2020)
About Aihika Herbocare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.29 M.
Swathi Paka, Krishnaveni Samala, and Sushila Kusuma serve as directors at the Company.
- CIN/LLPIN
U24230TG2016PLC111024
- Company No.
111024
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Jul 2016
- Date of AGM
25 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aihika Herbocare Limited offer?
Aihika Herbocare Limited offers a wide range of products and services, including Common Disease Medicines, Hair Growth Medicine, Pain Relief Drugs & Pharmaceuticals, Pain Killers, Skin Treatment Solution, Anti Aging Treatment, Health Care Service, Women Health Services, Medical Consultants & Clinics, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Aihika Herbocare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swathi Paka | Director | 03-Mar-2023 | Current |
Krishnaveni Samala  | Director | 03-Mar-2023 | Current |
| Sushila Kusuma | Director | 03-Mar-2023 | Current |
Financial Performance of Aihika Herbocare.
Aihika Herbocare Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 14.3% decrease. The company also saw a substantial improvement in profitability, with a 96.5% increase in profit. The company's net worth dipped by a decrease of 6.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aihika Herbocare?
In 2020, Aihika Herbocare had a promoter holding of 41.67% and a public holding of 58.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Jan 2017 | ₹2.29 M | Open |
How Many Employees Work at Aihika Herbocare?
Unlock and access historical data on people associated with Aihika Herbocare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aihika Herbocare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aihika Herbocare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
